Table 4 Screening implementation outcomes for the first 12Â months of screening
|  | Clinic 1 N (%) | Clinic 2 N (%) | Clinic 3 N (%) | Total N (%) |
|---|---|---|---|---|
Total patients with visits | 6861 | 9477 | 3962 | 20,300 (100.0%) |
Patients with eligible visitsa [N (% of total patients)] | 1644b (24.0%) | 1429 (15.1%) | 942 (23.8%) | 4015 (19.8%) |
Screening completed (N) | 1522 | 1319 | 878 | 3749 |
 Screening rate among patients with eligible visits (%) | 92.6% | 92.3% | 93.2% | 93.4% |
 Screening rate among patients with any visit (%) | 22.6% | 13.9% | 22.2% | 18.5% |
Self-administered screening [N (% of those screened)] | 1443 (93.0%) | 1221 (92.6%) | 818 (93.2%) | 3482 (92.9%) |
Moderate-high risk for tobaccoc | 261 (16.8%) | 156 (11.8%) | 131 (14.9%) | 548 (14.6%) |
 Moderate risk | 84 (5.4%) | 61 (4.6%) | 37 (4.2%) | |
 High risk | 177 (11.4%) | 120 (9.1%) | 94 (10.7%) | |
Moderate-high risk for alcoholc | 495 (31.9%) | 379 (28.7%) | 265 (30.2%) | 1139 (30.4%) |
 Moderate risk | 324 (20.9%) | 290 (22.0%) | 146 (16.6%) | |
 High risk | 171 (11.0%) | 170 (12.9%) | 119 (13.6%) | |
Moderate-high risk for cannabisc | 174 (11.2%) | 130 (9.9%) | 102 (11.6%) | 406 (10.8%) |
 Moderate risk | 105 (6.8%) | 103 (7.8%) | 57 (6.5%) | |
 High risk | 69 (4.4%) | 51 (3.9%) | 45 (5.1%) | |
Moderate-high risk for illicit drugsc,d | – | – | – | 12 (0.3%) |
Moderate-high risk for prescription drugsc,d | – | – | – | 23 (0.6%) |
Counseling documentede | 88/569 (15.5%) | 94/520 (18.1%) | 61/304 (20.1%) | 243/1393 (17.4%) |